• About Us
  • Our Products
  • Patients
  • Surgeons
  • Investors
  • Contact Us
Investor Relations Contacts

Home > Investors > Investor Relations Contacts

Investor Relations Contacts

For information on investing in ReGen Biologics, contact:

Brion D. Umidi
Senior Vice President and Chief Financial Officer
ReGen Biologics, Inc.
bumidi@regenbio.com

Cameron Associates
1370 Avenue of the Americas, Suite 902
New York, NY  10019-4602
Al Palombo                                               Lester Rosenkrantz
(212) 245-5488                                        (212) 245-5486
al@cameronassoc.com                        lester@cameronassoc.com


Code of Ethics Contacts:

Gerald E. Bisbee, Jr., Ph.D.
Chairman, President and CEO
ReGen Biologics, Inc.
gbisbee@regenbio.com

Brion D. Umidi
Senior Vice President and Chief Financial Officer
ReGen Biologics, Inc.
bumidi@regenbio.com  

Alan W. Baldwin
ReGen Biologics, Inc. Director and Chairman - Audit Committee
1400 Winstead Drive
Fallston, MD  21047
(443) 742-8509
awrenb7@comcast.net


Transfer Agent Information and Contacts:

For information on how to conduct transactions on restricted stock, go to the Investor FAQ page of the web site.

Computershare address for shareholder requests Via First Class/Registered Mail:

         Computershare Trust Company, N. A.
         Post Office Box 43010
         Providence, RI  02940-3010

Use the following address for shareholder requests sent via Private Carrier (FedEx, etc):

         Computershare Trust Company N. A.
         66 Brooks Drive
         Braintree, MA  02184

Shareholders can send Computershare their questions via the Internet from www.computershare.com and access answers to many frequently asked questions, including information regarding name changes or transfer of shares at http://www.computershare.com/shs/faq/index_faq.htm .

Shareholder services phone number for ReGen Biologics, Inc. shareholders:  (877) 282-1168.

Relevant Phone Numbers:

         (877) 282-1168  Shareholder Information
         (781) 575-2518  Hearing Impaired within U.S.
         (781) 575-2692  Hearing Impaired outside U.S.


NeboWeb Content Management System Tracking